| |
|
|
Hanmi Pharm (008930) |
|
|
STOCK |
|
|
| Address |
893-5,HAJEO-RI , PALTAN-MYEON, HWASEONG-SI, GYEONGGI-DO |
| Home Page |
www.hanmi.co.kr
|
| Established |
1973. 6.15 |
Tel |
031-356-3311-4 |
| Listed |
1988. 6.20 |
IR |
02-410-9031 |
| Common shares O/S |
8,697,970 |
President |
Im,Seong Gi/Im,Seon Min |
| Preferred shares O/S |
|
No.of Employees |
1,845(2008. 3) |
| Sales increased on steady demand for specialized medicines and new drugs. Its net profit fell on heavy fines, although its operating income increased. The company is seeking to develop new drugs, and its three new drugs are scheduled to be under clinical tests. |
| Sales are expected to post a steady rise on robust sales of its new drugs such as Slimmer. Its presence in the Chinese market is forecast to be solidified on increased sales. Its advance into the U.S. market is likely to accelerate on increased sales of syringe-type antibiotics made by its affiliate. |
|
  |
(date: 2007.12, unit : %) |
| Name |
Lim Seonggi |
BONY-MATTHEWSIF |
National Pension Fund |
| Portion |
19.4 |
6.5 |
6.4 |
|
 |
(unit : %) |
| Sales |
Tablets Parts |
45.6 |
Cost |
Raw Materials |
|
| Flexible/Inflexible Capsule |
16.7 |
Labors |
|
| injection Part |
16.6 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
04. 4 |
05. 1 |
06. 1 |
07. 1 |
08. 1 |
| Type |
SD |
BI |
BI |
BI |
BI |
| Amount |
8.30 |
12.02 |
9.06 |
9.51 |
9.99 |
|
|
|
|
